ClinicalTrials.gg
RecruitingNCT06665607Updated Nov 1, 2024

Foot Muscles Training in Sclerosis

An interventional study of Intrinsic Mucle Training in Multiple Sclerosis, Muscle Weakness and Training Group, Sensitivity, sponsored by Inés Llamas-Ramos. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-11-01.

Sponsored by Inés Llamas-Ramos · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 230 studies in Multiple Sclerosis with a site in Spain — 35 open to participants now, 56 under way, 14 of them phase 3. Multiple Sclerosis · Spain.

Planned enrollment
153rd of 202
34 · median 137
Started
2024
with 17 others
No phase
68 of 230
22 open now
Primary completion
2025-06
later than 10 of 55 live
Registered
188th of 230
by date

Among the 230 studies in Multiple Sclerosis with a site in Spain, this one is the 153rd largest by planned enrollment of the 202 interventional ones that give a count, is one of 18 that started in 2024, is one of 68 with no phase, reaches primary completion later than 10 of the 55 other live ones, and was the 188th registered.

Multiple Sclerosis

3,273 studies on the registry are indexed under Multiple Sclerosis; 665 are open to participants now.

Browse Multiple Sclerosis studies →

Open to participants now

35 of the 230 studies in Multiple Sclerosis with a site in Spain are open now. Recruiting first, the newest first:

29 more — sign in →

All 35 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 434 Multiple Sclerosis studies recruiting now, 164 (38%) set no upper age limit and 214 (49%) stop at 75 or younger; 40 take children under 18; 95 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 230 studies in Multiple Sclerosis with a site in Spain, or all of them as a file.
02

Study summary

The study tries to assess the efficacy of an 8-week IFM training programme on stability in patients diagnosed with Multiple Sclerosis

03

Conditions studied

  • Multiple Sclerosis
  • Muscle Weakness
  • Training Group, Sensitivity
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with moderate neurological disability as scored by the Expanded Disability Status Scale (EDSS), ranging from 3.0 to 6.0

Exclusion criteria

Exclusion Criteria:

  • Cognitive disturbances that could affect the performance of any of the tests or questionnaires included in the study
  • Diagnosis of visual or vestibular disorders that could affect patient stability
  • Change in Multiple Sclerosis-specific medication in the 2 months prior to the start of the study
  • Acute relapse in the 2 months prior to the start of the study
  • Traumatologic or orthopaedic disorders that could negatively affect balance.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
34 participants (estimated)

Study arms

  • Experimental
    Training Group

    Procedure: Intrinsic Mucle Training

  • Sham comparator
    Control Group

    Procedure: Intrinsic Mucle Training

Interventions

  • ProcedureIntrinsic Mucle Training

    Conventional physiotherapy treatment and the intrinisc foot muscles strengthening program for 8 weeks.

06

What researchers measure

Primary outcomes

  1. Four Square Step Test (FSST): dynamic stability assessment test.

    The test consists of drawing a cross on the floor, delimiting 4 squares. The subject is placed in square number 1 in front of square number 2. The objective is to enter as quickly as possible into each square following the following sequence: Square number 1, 2, 3, 4, 1, 4, 4, 3, 2 and 1. It measures time.

    Time frame: Initial and after 8 weeks

  2. Six Spot Step Test (SSST): test that quantitatively assesses lower limb function

    The test field measured one meter (width) by five meters (length). In the middle of the width line (0.50 m), a cone was placed in the proximal and distal areas of the line (start point and finish point). On each lateral line, two cones were placed at distances of one and three meters on the left. Another two cones were placed at two and four meters on the right. The subjects were instructed to walk on alternating sides and to kick the cones, alternating between the medial and lateral sides of the same foot. The subjects were instructed to complete the test as quickly as possible, without running. It measures distance.

    Time frame: Initial and after 8 weeks

  3. The Frailty and Injuries: Cooperative Studies of Intervention Tecnhiques (FICSIT-4 test): Test of static balance

    Participants have to maintain four progressively difficult foot positions for 10 seconds each (side by side stance, semi-tandem stance, tanden stance, unipedal stance). It measures the ability to maintain posture without losing balance is evaluated.

    Time frame: 0-9 points. Initial and after 8 weeks

  4. Activities-specific Balance Confidence scale (AsBC)

    Evaluate the patient´s perceived of balance confidence during 16 different daily activities. 0%-100%

    Time frame: Initial and after 8 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2024; primary completion for Jun 2025, 7 months later.

Of 852 non-industry interventional studies with no phase under Multiple Sclerosis, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 43. This study's planned 7 months is below that.

Counting every sponsor, half of 874 studies reached it within 21 months; a quarter within 9 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 29, 2024
First posted
Oct 30, 2024
StartEst.
Nov 4, 2024
Primary completionEst.
Jun 30, 2025
CompletionEst.
Jul 15, 2025
Last update
Nov 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06665607
Lead sponsor
Inés Llamas-Ramos
Responsible party
Inés Llamas-Ramos (PhD, University of Salamanca) — Sponsor-investigator
First posted
Oct 30, 2024
Start date
Nov 4, 2024 (estimated)
Primary completion
Jun 30, 2025 (estimated)
Completion
Jul 15, 2025 (estimated)
Last update
Nov 1, 2024

Study contacts

Daniel García García, PhD
Contact
daniel.ggarcia@uva.es
620712485
Inés Llamas Ramos, PhD
Contact
inesllamas@usal.es
663005052

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion